APA

Ludmerer S. W., Hirano T., Black S., Howe A. Y. M., Chang W., Takase A., Nakamura K., Tanaka Y., Kumada H., Hayashi N. & Nickle D. (20171116). HCV evolutionary genetics of SVR versus virologic failure assessed from the vaniprevir phase III registration trials. : Antiviral research.

Chicago

Ludmerer Steven W, Hirano Tomona, Black Stuart, Howe Anita Y M, Chang Wei, Takase Akiko, Nakamura Keisuke, Tanaka Yoshiyuki, Kumada Hiromitsu, Hayashi Norio and Nickle David. 20171116. HCV evolutionary genetics of SVR versus virologic failure assessed from the vaniprevir phase III registration trials. : Antiviral research.

Harvard

Ludmerer S. W., Hirano T., Black S., Howe A. Y. M., Chang W., Takase A., Nakamura K., Tanaka Y., Kumada H., Hayashi N. and Nickle D. (20171116). HCV evolutionary genetics of SVR versus virologic failure assessed from the vaniprevir phase III registration trials. : Antiviral research.

MLA

Ludmerer Steven W, Hirano Tomona, Black Stuart, Howe Anita Y M, Chang Wei, Takase Akiko, Nakamura Keisuke, Tanaka Yoshiyuki, Kumada Hiromitsu, Hayashi Norio and Nickle David. HCV evolutionary genetics of SVR versus virologic failure assessed from the vaniprevir phase III registration trials. : Antiviral research. 20171116.